Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report

Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report

Yanmei Peng,1 Huijuan Cui,2 Zhe Liu,3 Daiwei Liu,1 Fan Liu,1 Yazhong Song,1 Hua Duan,1 Yuqin Qiu,1 Qiang Li1 1Department of China-Japan Friendship Hospital, Beijing University of Chinese Medicine, 2Department of Oncology, China-Japan Friendship Hospital, Chaoyang, 3Department of Oncology, Beijing C...

Full description

Bibliographic Details
Main Authors: Peng Y, Cui H, Liu Z, Liu D, Liu F, Song Y, Duan H, Qiu Y, Li Q
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:OncoTargets and Therapy
Subjects:
advanced non-small cell lung cancer
apatinib
erlotinib
venous thromboembolism
dabigatran
Online Access:https://www.dovepress.com/apatinib-to-combat-egfr-tki-resistance-in-an-advanced-non-small-cell-l-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/apatinib-to-combat-egfr-tki-resistance-in-an-advanced-non-small-cell-l-peer-reviewed-article-OTT

Similar Items